Literature DB >> 23908454

Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria.

Joanne T Marsden1, David C Rees.   

Abstract

BACKGROUND AND OBJECTIVES: The porphyrias are a group of rare, mainly inherited, diseases caused by a deficiency of one of the enzymes of the haem biosynthesis pathway. The biochemical hallmark of an acute attack is an increase in urine porphobilinogen (PBG), together with an increase in urinary excretion of δ-aminolaevulinic acid (ALA) and total urine porphyrins (TUP). In patients with acute intermittent porphyria (AIP) the concentrations of the porphyrin precursors are thought to remain elevated for many years following an acute attack, although this has not been well documented.
METHODS: We measured urine ALA, PBG and TUP excretion in 20 patients with AIP following an attack of acute porphyria over a time period of 3 months to 23 years after their last documented acute attack.
RESULTS: We showed that urinary concentrations of all metabolites remain elevated for many years. The urinary half life of TUP was 5.3 years, ALA 7.7 years and PBG 10.6 years. Even after 20 years, PBG concentrations remained elevated above the normal range.
CONCLUSIONS: Our study highlights the difficulties of using urinary analysis for diagnosing recurrent attacks, and also raises important questions about the pathophysiology of the condition.

Entities:  

Keywords:  Inherited Pathology; Laboratory Tests; Metabolism

Mesh:

Substances:

Year:  2013        PMID: 23908454     DOI: 10.1136/jclinpath-2012-201367

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.

Authors:  Nicolas Pallet; Iadh Mami; Caroline Schmitt; Zoubida Karim; Arnaud François; Marion Rabant; Dominique Nochy; Laurent Gouya; Jean-Charles Deybach; Yichum Xu-Dubois; Eric Thervet; Hervé Puy; Alexandre Karras
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

Review 2.  [Porphyrias-what is verified?]

Authors:  U Stölzel; I Kubisch; T Stauch
Journal:  Internist (Berl)       Date:  2018-12       Impact factor: 0.743

Review 3.  The acute hepatic porphyrias.

Authors:  Bruce Wang
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

4.  A Simple Method for Quantification of Five Urinary Porphyrins, Porphobilinogen and 5-Aminolevulinic Acid, Using Liquid Chromatography Tandem Mass Spectrometry.

Authors:  Ozlem Dogan; Muhittin A Serdar; Koza Murat; Cigdem Sonmez; Emre İspir; Mustafa Serteser; Ibrahim Unsal
Journal:  Indian J Clin Biochem       Date:  2017-11-10

Review 5.  Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management.

Authors:  Mohamed Kazamel; Robert J Desnick; John G Quigley
Journal:  Curr Neurol Neurosci Rep       Date:  2020-10-07       Impact factor: 5.081

Review 6.  Acute hepatic porphyria and anaesthesia: a practical approach to the prevention and management of acute neurovisceral attacks.

Authors:  N Wilson-Baig; M Badminton; D Schulenburg-Brand
Journal:  BJA Educ       Date:  2020-12-09

Review 7.  Nutrients and Porphyria: An Intriguing Crosstalk.

Authors:  Elena Di Pierro; Francesca Granata
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

8.  High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor.

Authors:  María Barreda-Sánchez; Juan Buendía-Martínez; Guillermo Glover-López; Carmen Carazo-Díaz; María Juliana Ballesta-Martínez; Vanesa López-González; María José Sánchez-Soler; Lidya Rodriguez-Peña; Ana Teresa Serrano-Antón; Remedios Gil-Ferrer; Maria Del Carmen Martínez-Romero; Pablo Carbonell-Meseguer; Encarna Guillén-Navarro
Journal:  Orphanet J Rare Dis       Date:  2019-02-26       Impact factor: 4.123

9.  EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.

Authors:  Laurent Gouya; Paolo Ventura; Manisha Balwani; D Montgomery Bissell; David C Rees; Ulrich Stölzel; John D Phillips; Raili Kauppinen; Janneke G Langendonk; Robert J Desnick; Jean-Charles Deybach; Herbert L Bonkovsky; Charles Parker; Hetanshi Naik; Michael Badminton; Penelope E Stein; Elisabeth Minder; Jerzy Windyga; Radan Bruha; Maria Domenica Cappellini; Eliane Sardh; Pauline Harper; Sverre Sandberg; Aasne K Aarsand; Janice Andersen; Félix Alegre; Aneta Ivanova; Neila Talbi; Amy Chan; William Querbes; John Ko; Craig Penz; Shangbin Liu; Tim Lin; Amy Simon; Karl E Anderson
Journal:  Hepatology       Date:  2019-11-07       Impact factor: 17.425

10.  Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control study.

Authors:  Oscar J Pozo; Josep Marcos; Andreu Fabregat; Rosa Ventura; Gregori Casals; Paula Aguilera; Jordi Segura; Jordi To-Figueras
Journal:  Orphanet J Rare Dis       Date:  2014-04-16       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.